CRYOPORT, INC. Investment Income, Interest
CRYOPORT, INC. (CYRX) reported Investment Income, Interest of $0 for the 12-month period ending 2013-03-31, per its 10-K filed 2013-06-25.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2013-06-25
- CRYOPORT, INC. investment income, interest for the quarter ending 2012-03-31 was -$573.00, a 112.26% decline year-over-year.
- CRYOPORT, INC. investment income, interest for the quarter ending 2011-12-31 was $698.00, a 80.32% decline year-over-year.
- CRYOPORT, INC. investment income, interest for the quarter ending 2011-09-30 was $4.96K, a 26.79% increase year-over-year.
- CRYOPORT, INC. investment income, interest for the quarter ending 2011-06-30 was $6.86K, a 99.45% increase year-over-year.
- CRYOPORT, INC. investment income, interest for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- CRYOPORT, INC. investment income, interest for fiscal 2012 was $11.94K, a 23.32% decline from fiscal 2011.
- CRYOPORT, INC. investment income, interest for fiscal 2011 was $15.57K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2013-03-31 | $0.00 10-K · filed 2013-06-25 | |||
| 2012-03-31 | -$573.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25 | $125.00 derived: sum of 2 quarters · filed 2013-06-25 | $5.08K derived: sum of 3 quarters · filed 2013-06-25 | $11.94K 10-K · filed 2013-06-25 |
| 2011-12-31 | $698.00 10-Q · filed 2013-02-14 | $5.66K derived: sum of 2 quarters · filed 2013-02-14 | $12.51K 10-Q · filed 2013-02-14 | $17.19K derived: sum of 4 quarters · filed 2013-02-14 |
| 2011-09-30 | $4.96K 10-Q · filed 2012-11-09 | $11.81K 10-Q · filed 2012-11-09 | $16.49K derived: sum of 3 quarters · filed 2012-11-09 | $20.04K derived: sum of 4 quarters · filed 2012-11-09 |
| 2011-06-30 | $6.86K 10-Q · filed 2012-08-14 | $11.53K derived: sum of 2 quarters · filed 2012-08-14 | $15.08K derived: sum of 3 quarters · filed 2012-08-14 | $18.99K derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $4.67K derived: 10-K 12 month − 10-Q 9 month · filed 2012-06-27 | $8.22K derived: sum of 2 quarters · filed 2012-06-27 | $12.13K derived: sum of 3 quarters · filed 2012-06-27 | $15.57K 10-K · filed 2012-06-27 |
| 2010-12-31 | $3.55K 10-Q · filed 2012-02-21 | $7.46K derived: sum of 2 quarters · filed 2012-02-21 | $10.90K 10-Q · filed 2012-02-21 | |
| 2010-09-30 | $3.91K 10-Q · filed 2011-11-14 | $7.35K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $3.44K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |